New and Emerging Therapies for Pediatric Atopic Dermatitis

• Results Overview

  This review discusses new treatments for eczema in children, including recently FDA-approved medications (crisaborole and dupilumab) and promising emerging therapies that target specific pathways in the immune system, potentially offering better effectiveness with fewer side effects than traditional treatments.

• Study Summary

  Num Participants:

  None

  Study Type:

  Review

  Control Group:

  None

  Efficacy End Points Treatment:

  None

  Efficacy End Points Control:

  None

  Side Effects Treatment:

  Adverse Event	Severity	Percentage Affected

  Side Effects Control:

  Adverse Event	Severity	Percentage Affected